A carregar...
Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma
BACKGROUND: The role of immunotherapy in cancer is now well-established, and therapeutic options such as checkpoint inhibitors are increasingly being approved in many cancers such as non-small cell lung cancer (NSCLC). Malignant pleural mesothelioma (MPM) is a rare orphan disease associated with pri...
Na minha lista:
| Publicado no: | BMC Pulm Med |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8097826/ https://ncbi.nlm.nih.gov/pubmed/33952230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-021-01513-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|